Press Releases Onconetix, Inc.

Equities

ONCO

US09610B1089

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
0.1561 ^USD	-2.25%		-6.64%	-21.16%

Jun. 14	Onconetix, Inc. Announces the Appointment of Karina M. Fedasz as Interim Chief Financial Officer	CI
May. 20	Tranche Update on Onconetix, Inc.'s Equity Buyback Plan announced on November 10, 2022.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Number of shares and votes in Oncopeptides	Jul. 01	AQ
Onconetix : RELEASE OF CLAIMS Form 8 K	Jun. 13	PU
Bulletin from the Annual General Meeting in Oncopeptides AB (publ)	Jun. 03	AQ
Oncopeptides AB - First patients in Spain to be treated with Pepaxti	May. 28	AQ
Immunovia Publishes Interim Report for January-March 2024	Apr. 29	AQ
Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors	Feb. 13	AQ
Nasdaq Stocks Under $1 to Watch Now! VTAK, IVP, ONCO, AKTS, RDHL	Jan. 31	AQ
Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders	Dec. 19	AQ
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™	Dec. 18	AQ
Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company	Nov. 02	AQ
Blue Water Biotech : Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company - Form 8-K	Nov. 02	PU
Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)	Nov. 01	AQ
Blue Water Biotech Issues Letter to Shareholders	23-10-30	AQ
Blue Water Biotech : GENERAL RELEASE OF CLAIMS - Form 8-K	23-10-10	PU
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO	23-10-10	AQ
Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q	23-08-28	AQ
Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’s Commercial Products	23-08-10	AQ
Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds	23-08-01	AQ
Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians	23-07-31	AQ
Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®	23-07-25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Onconetix, Inc.

Equities

ONCO

US09610B1089

Press Releases

Filters